Wilson Sonsini Goodrich & Rosati represented Impossible Foods in the case. Impossible Foods secured a victory in a patent infringement litigation that Impossible filed against Motif...
Impossible Foods Inc. v. Motif Foodworks, Inc.
Third Arc Bio’s $165 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Vida Ventures on IP matters related to the transaction. Third Arc Bio Inc., a biotech company, announced a $165 million...
Lunar Energy’s $300 Million Funding Rounds
Wilson Sonsini advised Lunar Energy on the deal. Lunar Energy, a California-based start-up dedicated to delivering home electrification, emerged from stealth mode having successfully raised over...
Faeth Therapeutics’ $47 Million Series A Financing
Wilson Sonsini advised Faeth Therapeutics on the deal. Faeth Therapeutics, a cancer metabolism company, announced the completion of a Series A financing of $47 million led...
Synthekine’s Collaboration and License Agreement with Merck
Wilson Sonsini Goodrich & Rosati advised Synthekine on the deal. Synthekine Inc., an engineered cytokine therapeutics company, announced that it has entered into a worldwide research...
Avalara’s Acquisition of Track 1099
Wilson Sonsini Goodrich & Rosati advised Track 1099 on the deal. Avalara, a leading provider of tax compliance automation software for businesses of all sizes, has acquired...